MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,727 Cr | ₹1,473 Cr | ₹1,334 Cr | ₹845 Cr | ₹604 Cr |
What is the latest Net Current Assets ratio of MARKSANS PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,727 Cr |
| Mar2024 | ₹1,473 Cr |
| Mar2023 | ₹1,334 Cr |
| Mar2022 | ₹845 Cr |
| Mar2021 | ₹604 Cr |
How is Net Current Assets of MARKSANS PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,727 Cr | 17.26 | |
| Mar2024 | ₹1,473 Cr | 10.37 | |
| Mar2023 | ₹1,334 Cr | 57.91 | |
| Mar2022 | ₹845 Cr | 39.93 | |
| Mar2021 | ₹604 Cr | - | |
Compare Net Current Assets of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,831.3 Cr | -3.5% | -9.8% | -38.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,728.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,627.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -3.5% |
-9.8% |
-38.6% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses